Can You Give Steroids? It Depends on the Clinical Context
The decision to administer corticosteroids depends entirely on the specific clinical indication—steroids are strongly recommended for severe/critical COVID-19 and moderate-to-severe asthma exacerbations, but are contraindicated for empiric treatment of hoarseness/dysphonia without laryngoscopy and should not be routinely used for most cases of conjunctivitis or acute laryngitis.
When Steroids ARE Recommended
Severe or Critical COVID-19
- Systemic corticosteroids are strongly recommended for patients with severe or critical COVID-19, as they reduce 28-day mortality by 3.4% and probably reduce the need for mechanical ventilation 1
- The typical regimen involves 7-10 days of treatment, with dexamethasone being the preferred agent 1
- The benefits on mortality are deemed critically important, with minimal anticipated variability in patient preference when severely ill 1
Moderate-to-Severe Asthma Exacerbations
- Systemic corticosteroids should be administered to all patients with moderate-to-severe asthma exacerbations and those who fail to respond to initial β2-agonist therapy 1
- Oral prednisone is recommended as it has equivalent effects to intravenous methylprednisolone but is less invasive 1
- Early administration may reduce the likelihood of hospitalization in moderate-to-severe cases 1
Inflammatory Bowel Disease (Moderate-to-Severe)
- For moderate-to-severe Crohn's disease, oral prednisolone 40 mg daily is appropriate, with gradual tapering over 8 weeks 1, 2
- Intravenous steroids (hydrocortisone 400 mg/day or methylprednisolone 60 mg/day) are appropriate for severe disease 1, 2
- Budesonide 9 mg daily is suitable for isolated ileo-cecal disease with moderate activity 1, 2
Chronic Rhinosinusitis
- Topical intranasal steroids are effective for reducing symptoms of chronic rhinosinusitis and should be used for at least 8-12 weeks 1
- Long-term use has not been shown to affect systemic cortisol levels or increase ocular risks 1
When Steroids Are NOT Recommended
Hoarseness/Dysphonia Without Laryngoscopy
- Clinicians should NOT routinely prescribe corticosteroids for dysphonia prior to visualization of the larynx 1
- There are no studies supporting empiric steroid use for dysphonia except in special circumstances 1
- The potential for significant side effects (insomnia, gastrointestinal disturbances, mood changes, metabolic syndrome, cardiovascular risks) outweighs any unproven benefit 1
Acute Laryngitis
- Despite common prescription patterns, there is an overwhelming lack of supporting data for steroid efficacy in acute laryngitis 1
- The temptation to prescribe should be avoided due to potential serious side effects 1
ARDS/ALI (Routine Early Use)
- Do not routinely administer corticosteroids to patients at risk for or meeting criteria for ALI/ARDS 1
- Well-designed trials fail to demonstrate significant benefit for prevention or early treatment of ARDS 1
- Consider methylprednisolone only in persistent/refractory ARDS after actively excluding infection 1
Critical Safety Considerations
Contraindications and Cautions
- Use with extreme caution in patients with active or latent peptic ulcers, diverticulitis, fresh intestinal anastomoses, and nonspecific ulcerative colitis due to increased perforation risk 3
- Exercise caution in patients with diabetes (risk of hyperglycemia), immunocompromise, congestive heart failure, hypertension, or renal insufficiency 1, 3
- Avoid in patients with tuberculosis unless absolutely necessary for life-saving therapy 1
Dosing Principles
- Always use the lowest possible dose to control the condition, with gradual reduction when possible 3
- Short courses (<21 days) minimize risk, though side effects can occur even with brief use 1, 3
- Drug-induced adrenocortical insufficiency may persist up to 12 months after discontinuation following prolonged high-dose therapy 3
Monitoring Requirements
- For therapy >6 weeks, monitor intraocular pressure due to risk of elevated pressure, glaucoma, and cataracts 3
- In pediatric patients, carefully monitor growth velocity, blood pressure, weight, height, and bone health 3
- Consider osteoporosis prevention (calcium, vitamin D, bisphosphonates) for any patient anticipated to receive ≥5 mg prednisone equivalent for ≥3 months 3
Common Pitfalls to Avoid
- Never discontinue corticosteroids abruptly—gradual tapering is essential to prevent withdrawal syndrome and adrenal crisis 3
- Do not prescribe empirically without establishing a clear diagnosis, particularly for conditions like hoarseness where laryngoscopy is required first 1
- Warn patients about increased infection susceptibility, especially to chickenpox and measles, and advise seeking immediate medical attention if exposed 3
- Be aware that signs of peritoneal irritation following GI perforation may be minimal or absent in patients on steroids 3